Table 6. Relationship between peak CSF neurodegeneration biomarker levels and long-term outcome.
Outcome | CCSctf | NFHsmi35 | 14-3-3β | 14-3-3ζ | UCH-L1 | CCSntf | NSE | S100β |
GOSE 5-8 | 0.6 +/- 0.2 | 17.8 +/- 15.8 | 9.4 +/- 6.3 | 4.6 +/- 2.1 | 3.6 +/- 2.7 | 9.0 +/- 2.5 | 2.9 +/- 1.6 | 27 +/- 15 |
GOSE 1-4 | 2.0 +/- 0.5 | 22.3 +/- 17.8 | 17.5 +/- 6.8 | 20.5 +/- 7.7 | 8.2 +/- 3.2 | 44.3 +/- 21.9 | 17.3 +/- 5.0 | 127 +/- 59 |
P value | 0.04 | 0.86 | 0.41 | 0.08 | 0.29 | 0.15 | 0.03 | 0.14 |
The mean (+/- S.E.M.) peak level of each biomarker from 3–10 days post-rupture is depicted in relation to long-term outcome dichotomized according to the Glasgow Outcome Scale - Extended.